CITALOPRAM

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

유효 성분:

CITALOPRAM HYDROBROMIDE

제공처:

Chanelle Medical

ATC 코드:

N06AB04

INN (국제 이름):

CITALOPRAM HYDROBROMIDE

복용량:

10 Milligram

약제 형태:

Film Coated Tablet

처방전 유형:

Product subject to prescription which may not be renewed (A)

치료 영역:

citalopram

승인 상태:

Not Marketed

승인 날짜:

2006-07-07

환자 정보 전단

ID:
PL 106/107/108M (IRL NATIONAL)
VERSION: 08
EFFECTIVE DATE:
Page 1 of 12
PACKAGE LEAFLET-: INFORMATION FOR THE USER
CITALOPRAM 10 MG, 20 MG AND 40 MG FILM-COATED TABLETS
CITALOPRAM (AS HYDROBROMIDE)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you. Do not pass it on to
others. It may harm
them, even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet.
WHAT IS IN THIS LEAFLET:
1.
What Citalopram is and what it is used for
2.
What you need to know before you take Citalopram
3.
How to take Citalopram
4.
Possible side effects
5.
How to store Citalopram
6.
Contents of the pack and other information
1.
WHAT CITALOPRAM IS AND WHAT IT IS USED FOR?
HOW DOES CITALOPRAM WORK?
Citalopram belongs to a group of antidepressants called Selective
Serotonin Reuptake
Inhibitors (SSRIs).. These medicines act on the serotonin-system in
the brain by increasing
the serotonin level. Disturbances in the serotonin-system are
considered an important factor
in the development of depression and related diseases.
WHAT IS CITALOPRAM USED FOR?
Citalopram Film-Coated Tablets contains citalopram and is used for the
treatment of
depression and, when you feel better, to help prevent these symptoms
recurring.
Further, Citalopram is used for long-term treatment to prevent the
occurrence of new
depressive episodes in patients who have recurrent depression.
ID:
PL 106/107/108M (IRL NATIONAL)
VERSION: 08
EFFECTIVE DATE:
Page 2 of 12
Citalopram is also beneficial in relieving symptoms in patients prone
to panic attacks.
Ask your doctor if you have any questions about why Citalopram has
been prescribed for you.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE CITALOPRAM FILM-COATED
TABLETS

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Citalopram 10mg Film-coated Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablets contains Citalopram hydrobromide corresponding to 10 mg
citalopram base
Also contains 12.0 mg lactose monohydrate per tablet.
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Film-coated tablet
White to off-white coloured, round biconvex, film-coated tablets.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Depressive illness in the initial phase and as maintenance against
potential relapse/recurrence.
Citalopram is also indicated in the treatment of panic disorder with
or without agoraphobia.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
POSOLOGY
_Depression_
_Adults:_
Citalopram should be administered as a single oral dose of 20mg daily.
Depending on individual patient response, the
dose may be increased to a maximum of 40mg daily.
_Duration of Treatment_
The antidepressant effect usually sets in after 2 to 4 weeks.
Treatment with antidepressants is symptomatic and must
therefore be continued for an appropriate length of time, usually up
to 6 months after recovery in order to prevent
relapse. In patients with recurrent depression (unipolar) maintenance
therapy may need to be continued for a number of
years to prevent new episodes.
_Panic Disorder_
_Adults:_
A single oral dose of 10mg is recommended for the first week before
increasing the dose to 20mg daily.
Depending on
individual patient response, the dose may be increased to a maximum of
40 mg daily.
Duration of Treatment
Maximum effectiveness of citalopram in treating panic disorder is
reached after about 3 months and the response is
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___